Uncovering the role of oncogenic HER2 variants as drivers of pancreatic cancer.

被引：0
|
作者：
Kanu, Elishama
Sills, Joelle
Shelley, Rebecca
Ginzel, Joshua
Fernandes, Joseph
Agritelley, Ethan
Fletcher, Ash
Borowsky, Alexander D.
Shi, Chanjuan
Cardiff, Robert D.
Nussbaum, Daniel
Allen, Peter J.
Snyder, Joshua
机构：
[1] Duke Univ, Med Ctr, Durham, NC USA
[2] Duke Univ, Sch Med, Durham, NC USA
[3] Univ Calif Davis, Davis, CA USA
[4] Duke Univ, Med Ctr, Dept Surg, Durham, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2025年 / 43卷 / 4_SUPPL期
关键词：
D O I：
10.1200/JCO.2025.43.4_suppl.772
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：772 / 772
页数：1
相关论文
共 50 条
  • [21] EGFR and HER2: is there a role in ovarian cancer?
    Teplinsky, Eleonora
    Muggia, Franco
    TRANSLATIONAL CANCER RESEARCH, 2015, 4 (01) : 107 - 117
  • [22] Quantification of intratumoral heterogeneity of HER2 status in breast cancer.
    Horii, Rie
    Matsuura, Masaaki
    Nitta, Hiro
    Ito, Yoshinori
    Ohno, Shinji
    Iwase, Takuji
    Akiyama, Futoshi
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [23] Clinicopathologic features predicting HER2 overexpression in gastric cancer.
    Park, Ji Soo
    Jung, Minkyu
    Kim, Hye Ryun
    Rha, Sun Young
    Chung, Hyun Cheol
    Kim, Hyo Song
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [24] Integrin-mediated mechano-transduction controls HER2 oncogenic signaling and activation of YAP in breast cancer.
    Wang, Shimin
    Kim, Young-Mi
    Garippa, Ralph
    Norton, Larry
    Giancotti, Filippo G.
    MOLECULAR CANCER RESEARCH, 2020, 18 (08) : 22 - 22
  • [25] HER2 and gastric cancer. Recommendations for clinical practice in 2011
    Penault-Llorca, Frederique
    Chenard, Marie-Pierre
    Bouche, Olivier
    Emile, Jean-Francois
    Bibeau, Frederic
    Metges, Jean-Philippe
    Andre, Thierry
    Monges, Genevieve
    ANNALES DE PATHOLOGIE, 2011, 31 (02) : 78 - 87
  • [26] Her2/neu status in locally advanced breast cancer.
    Doran, CM
    Cameron, DA
    Watters, AD
    Leonard, RCF
    Bartlett, JMS
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 278 - 278
  • [27] Prevalence and role of HER2 mutations in cancer
    Cocco, Emiliano
    Lopez, Salvatore
    Santin, Alessandro D.
    Scaltriti, Maurizio
    PHARMACOLOGY & THERAPEUTICS, 2019, 199 : 188 - 196
  • [28] Biologic and therapeutic role of HER2 in cancer
    Ménard, S
    Pupa, SM
    Campiglio, M
    Tagliabue, E
    ONCOGENE, 2003, 22 (42) : 6570 - 6578
  • [29] Biologic and therapeutic role of HER2 in cancer
    Sylvie Ménard
    Serenella Marja Pupa
    Manuela Campiglio
    Elda Tagliabue
    Oncogene, 2003, 22 : 6570 - 6578
  • [30] Identification of novel HER2 splice variants in breast cancer
    Borras, A. M.
    Rogers, A.
    Kuang, Y.
    Flores, L.
    Distel, R.
    Krop, I. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345